10x Genomics, Inc. Class A Common Stock (TXG) Stock Price
TXGStock
$69.86+464.30%52W
Market Cap$9.10B
P/E—
PEG Ratio—
Div yield—
Beta2.02
TXG Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)171.79%
Price vs S&P 500 (4W)-10.36%
VGM Score44.61
TXG Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.02 | $0.03 | +258.37%(+$0.04) | |
| Q1 2026 | -$0.06 | $0.07 | +219.15%(+$0.13) | |
| Q4 2025 | -$0.04 | $0.07 | +276.25%(+$0.11) | |
| Q3 2025 | -$0.07 | -$0.02 | +67.43%(+$0.05) | |
| Q2 2025 | -$0.08 | $0.48 | +702.12%(+$0.56) |
TXG Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.67
3.70
3.70
3.70
Industry Peers — Lab Analytical Instruments(25)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
TXG10x Genomics, Inc. Class A Common Stock | F | D | A | 14.8x | 16.6% | 69.6% | -14.3% | $69.86 |
| AAgilent Technologies Inc. | D | C | A | 6.6x | 5.4% | 53.9% | 22.2% | $172.97 |
| WATWaters Corp | F | C | A | 9.4x | 6.0% | 50.9% | 7.1% | $436.95 |
| ILMNIllumina Inc | D | D | A | 8.8x | 6.0% | 66.4% | 19.5% | $262.54 |
| MTDMettler-Toledo International | D | C | A | 7.9x | 5.5% | 60.3% | 26.6% | $1622.29 |
| RVTYRevvity, Inc. | D | D | A | 5.8x | -5.5% | 55.0% | 12.3% | $152.64 |
| AVTRAvantor, Inc. | C | F | A | 1.7x | 0.5% | 31.8% | -4.7% | $16.42 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $364.15 |
| BIOBio-Rad Laboratories, Inc.Class A | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $353.70 |
| BRKRBruker Corporation | D | D | B | 2.4x | 11.6% | 47.7% | -1.5% | $54.80 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | A | B | — | — | — | — | $25.28 |
About 10x Genomics, Inc. Class A Common Stock
10x Genomics develops microfluidic-based instruments, consumables, and software for analyzing biological systems at high resolution and scale. The company's product portfolio includes the Chromium platform, Visium, and Xenium solutions, serving researchers and diagnostics customers globally across North America, Europe, Asia-Pacific, and China.